Home › Funds › Two Sigma Investments › CNTX
Two Sigma Investments position in CNTX
CONTEXT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)25.94K sh
Reported value held$14.37K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 56.53K | $63.00K | New |
| Q4 2022 | 26.53K | $17.29K | Reduce |
| Q1 2023 | 55.69K | $31.31K | Add |
| Q2 2023 | 26.84K | $42.94K | Reduce |
| Q2 2024 | 13.84K | $27.76K | New |
| Q3 2024 | 13.84K | $27.13K | Hold |
| Q2 2026 | 25.94K | $14.37K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CNTX
- Vanguard Group 3.79M sh · $5.57M · Q4 2025
- BlackRock Inc 6.17M sh · $3.42M · Q2 2026
- Franklin Resources 3.80M sh · $2.11M · Q2 2026
- Geode Capital Management 1.83M sh · $1.01M · Q2 2026
- Renaissance Technologies 1.04M sh · $576.83K · Q2 2026
- Northern Trust Corp 615.58K sh · $340.97K · Q2 2026
- Marshall Wace 384.53K sh · $211.49K · Q2 2026
- Charles Schwab Investment Management 227.85K sh · $126.21K · Q2 2026
- Millennium Management 147.29K sh · $81.58K · Q2 2026
- BNY Mellon 109.36K sh · $60.58K · Q2 2026
- Deutsche Bank AG 90.88K sh · $49.98K · Q2 2026
- Wells Fargo & Co 84.98K sh · $47.07K · Q2 2026